Nath Bio-Genes (India) Ltd - Stock Valuation and Financial Performance

BSE: 537291 | NSE: NATHBIOGEN | Agriculture | Small Cap

Nath Bio-Genes Share Price

173.75 -3.15 -1.78%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Nath Bio-Genes

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Nath Bio-Genes (India) stock performance -

mw4me loader
P/E Ratio (SA):
8.06
Market Cap:
330.2 Cr.
52-wk low:
139.5
52-wk high:
243.7

Is Nath Bio-Genes (India) Ltd an attractive stock to invest in?

1. Is Nath Bio-Genes (India) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Nath Bio-Genes (India) Ltd is a below average quality company.

2. Is Nath Bio-Genes (India) Ltd undervalued or overvalued?

The key valuation ratios of Nath Bio-Genes (India) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Nath Bio-Genes (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nath Bio-Genes (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Nath Bio-Genes:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nath Bio-Genes (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 30%24.4%12%8.3%8.4%7.9%9.2%9.2%-8.9%6.4%-
Value Creation
Index
1.10.7-0.1-0.4-0.4-0.4-0.3-0.3-1.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 172185162170192231280308278301335
Sales YoY Gr.-7.7%-12.5%4.8%12.8%20.5%21.2%9.9%-9.5%8.2%-
Adj EPS 15.215.88.810.115.520.126.429.3-35.518.321.6
YoY Gr.-4.4%-44.1%14.7%52.6%30%31.5%10.9%-221.2%NA-
BVPS (₹) 51.166.975.8189.5246.9267.1293.4322.7285.2301.7320.2
Adj Net
Profit
24.325.314.116.229.438.250.255.7-67.534.941
Cash Flow from Ops. 155.9-13.63.3-47-22.99.51.117.138.4-
Debt/CF from Ops. 1.53.8-4.322.1-0.7-2.57.490.65.52.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.4%9.5%2.5%8.2%
Adj EPS 2.1%3.5%-11.5%NA
BVPS21.8%4.1%0.9%5.8%
Share Price 6.4% -17.8% -16.7% 23.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
34.926.812.47.67.67.89.49.5-11.76.36.9
Op. Profit
Mgn %
19.618.815.217.121.118.819.621.813.416.315.7
Net Profit
Mgn %
14.113.78.79.615.316.61818.1-24.211.612.3
Debt to
Equity
0.30.20.50.20.10.10.10.20.20.2-
Working Cap
Days
298365490500520553552572652600835
Cash Conv.
Cycle
150169262263264280271301360313488

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.90%

Sales growth is good in last 4 quarters at 26.69%

Sales growth has been subdued in last 3 years 2.49%

Net Profit has been subdued in last 3 years -11.48%

Latest Financials - Nath Bio-Genes (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 21.6 21.3
TTM Sales (₹ Cr.) 335 335
BVPS (₹.) 320.2 319.9
Reserves (₹ Cr.) 590 589
P/BV 0.54 0.54
PE 8.06 8.15
From the Market
52 Week Low / High (₹) 139.45 / 243.70
All Time Low / High (₹) 38.90 / 585.00
Market Cap (₹ Cr.) 330
Equity (₹ Cr.) 19
Face Value (₹) 10
Industry PE 22.6

Management X-Ray of Nath Bio-Genes:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *15.1816.478.389.3416.3816.3816.3816.3816.3816.38
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Nath Bio-Genes

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales172185162170192231280308278301
Operating Expenses 138151137141151188225241241252
Manufacturing Costs73100887088144181162129112
Material Costs0-26-201210-25-41-13917
Employee Cost 13161414121619242523
Other Costs 526156454252676779100
Operating Profit 34352529404355673749
Operating Profit Margin (%) 19.6%18.7%15.2%17.1%21.1%18.8%19.6%21.7%13.4%16.3%
Other Income 1111122221
Interest 45610105791110
Depreciation 5443111333
Exceptional Items 00000000-890
Profit Before Tax 2626151730394957-6336
Tax 111010-2141
Profit After Tax 2425141629385056-6735
PAT Margin (%) 14.1%13.7%8.7%9.6%15.4%16.6%18.0%18.1%-24.2%11.7%
Adjusted EPS (₹)15.215.98.910.215.520.226.629.3-35.418.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%7%-6%11%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 82107121303469508558613542573
Share Capital 16161616191919191919
Reserves 6691105287450489539594523554
Minority Interest0000000000
Debt212158693258709992104
Long Term Debt111520010110
Short Term Debt202043493257709992104
Trade Payables39524844375068354328
Others Liabilities 47453938323234426387
Total Liabilities 189225266454570648729790740793

Fixed Assets

Gross Block176182224228250265267267270
Accumulated Depreciation0485216171819202225
Net Fixed Assets171330207211232246247245244
CWIP 0000000000
Investments 5555555555
Inventories89117141130123155204226220208
Trade Receivables35454552821081071098697
Cash Equivalents 221645212229438
Others Assets42444354104126145173180200
Total Assets 189225266454570648729790740793

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 156-143-47-23911738
PBT 2626151730394957-6336
Adjustment 89101310571010213
Changes in Working Capital -18-28-39-26-87-64-45-65-19-10
Tax Paid -1-1000-3-20-3-1
Cash Flow From Investing Activity -16-2-17-4-4-20-14-10-20-3
Capex -3-1-7-4-5-22-16-4-1-3
Net Investments 0000000000
Others -13-1-100021-7-190
Cash Flow From Financing Activity 1-43059020616-22-2
Net Proceeds from Shares 000013600000
Net Proceeds from Borrowing 0-1145-2000000
Interest Paid -4-5-6-10-10-5-7-9-11-10
Dividend Paid 00000000-4-4
Others 412210-17251225-813
Net Cash Flow 0-10539-2317-2534
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)34.9126.8912.47.677.627.879.489.51-11.666.31
ROCE (%)32.7326.4913.859.59.28.289.249.78-7.827.09
Asset Turnover Ratio1.040.90.660.470.370.380.410.410.360.39
PAT to CFO Conversion(x)0.630.24-10.19-1.62-0.610.180.02N/A1.09
Working Capital Days
Receivable Days6079102104127150140128128111
Inventory Days176202290291242220235256293259
Payable Days0-634-9051,3621,554-634-528-1,4721,663744

Nath Bio-Genes (India) Ltd Stock News

Nath Bio-Genes (India) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Nath Bio-Genes on 28-Mar-2024 16:01 is ₹173.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Nath Bio-Genes stood at ₹330.2.
The latest P/E ratio of Nath Bio-Genes as of 28-Mar-2024 16:01 is 8.06.
The latest P/B ratio of Nath Bio-Genes as of 28-Mar-2024 16:01 is 0.54.
The 52-week high of Nath Bio-Genes is ₹243.7 and the 52-week low is ₹139.4.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nath Bio-Genes is ₹334.5 ( Cr.) .

About Nath Bio-Genes (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.